0001654954-18-009332.txt : 20180817
0001654954-18-009332.hdr.sgml : 20180817
20180817164234
ACCESSION NUMBER: 0001654954-18-009332
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180817
DATE AS OF CHANGE: 20180817
EFFECTIVENESS DATE: 20180817
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: GT Biopharma, Inc.
CENTRAL INDEX KEY: 0000109657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 941620407
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-319563
FILM NUMBER: 181026218
BUSINESS ADDRESS:
STREET 1: 1825 K STREET
STREET 2: SUITE 510
CITY: WASHINGTON, D.C.
STATE: DC
ZIP: 33602
BUSINESS PHONE: (800) 304-9888
MAIL ADDRESS:
STREET 1: 1825 K STREET
STREET 2: SUITE 510
CITY: WASHINGTON, D.C.
STATE: DC
ZIP: 33602
FORMER COMPANY:
FORMER CONFORMED NAME: OXIS INTERNATIONAL INC
DATE OF NAME CHANGE: 19940916
FORMER COMPANY:
FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/
DATE OF NAME CHANGE: 19850312
D
1
primary_doc.xml
X0708
D
LIVE
0000109657
GT Biopharma, Inc.
100 SOUTH ASHLEY DRIVE
STE 600
TAMPA
FL
FLORIDA
33602
800-304-9888
FLORIDA
Oxis International Inc.
DDI Pharmaceuticals Inc.
Diagnostic Data Inc. /DE/
OXIS INTERNATIONAL INC
DDI PHARMACEUTICALS INC
DIAGNOSTIC DATA INC /DE/
Corporation
true
Steven
Weldon
100 SOUTH ASHLEY DRIVE
STE 600
TAMPA
FL
FLORIDA
33602
Director
Executive Officer
Anthony
J.
Cataldo
100 SOUTH ASHLEY DRIVE
STE 600
TAMPA
FL
FLORIDA
33602
Director
Kathleen
Clarence-Smith
100 SOUTH ASHLEY DRIVE
STE 600
TAMPA
FL
FLORIDA
33602
Director
Geoffrey
B.
Davis
100 SOUTH ASHLEY DRIVE
STE 600
TAMPA
FL
FLORIDA
33602
Director
Peter
Kiener
100 SOUTH ASHLEY DRIVE
STE 600
TAMPA
FL
FLORIDA
33602
Director
Jon
Bonfiglio
100 SOUTH ASHLEY DRIVE
STE 600
TAMPA
FL
FLORIDA
33602
Director
Raymond
Urbanski
100 SOUTH ASHLEY DRIVE
STE 600
TAMPA
FL
FLORIDA
33602
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2018-08-02
false
true
false
0
5140000
5140000
0
false
13
0
0
0
None, other than compensation to executive officers in their roles as employees.
GT Biopharma, Inc.
/s/ Steven Weldon
Steven Weldon
Chief Financial Officer
2018-08-16